DE19681033D2 - Verfahren zur Quantifizierung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits - Google Patents

Verfahren zur Quantifizierung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits

Info

Publication number
DE19681033D2
DE19681033D2 DE19681033T DE19681033T DE19681033D2 DE 19681033 D2 DE19681033 D2 DE 19681033D2 DE 19681033 T DE19681033 T DE 19681033T DE 19681033 T DE19681033 T DE 19681033T DE 19681033 D2 DE19681033 D2 DE 19681033D2
Authority
DE
Germany
Prior art keywords
quantification
tumor cells
body fluid
test kits
suitable test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19681033T
Other languages
English (en)
Inventor
Michael W Dahm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7777659&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE19681033(D2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority to DE19681033T priority Critical patent/DE19681033D2/de
Application granted granted Critical
Publication of DE19681033D2 publication Critical patent/DE19681033D2/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE19681033T 1995-11-16 1996-11-14 Verfahren zur Quantifizierung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits Ceased DE19681033D2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19681033T DE19681033D2 (de) 1995-11-16 1996-11-14 Verfahren zur Quantifizierung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19542795 1995-11-16
DE19681033T DE19681033D2 (de) 1995-11-16 1996-11-14 Verfahren zur Quantifizierung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits
PCT/DE1996/002183 WO1997018322A2 (de) 1995-11-16 1996-11-14 Verfahren zur quantifizierung von tumorzellen in einer körperflüssigkeit und dazu geeignete testkits

Publications (1)

Publication Number Publication Date
DE19681033D2 true DE19681033D2 (de) 1999-03-18

Family

ID=7777659

Family Applications (2)

Application Number Title Priority Date Filing Date
DE59609347T Expired - Lifetime DE59609347D1 (de) 1995-11-16 1996-11-14 Verfahren zur quantifizierung von tumorzellen in einer körperflüssigkeit und dazu geeignete testkits
DE19681033T Ceased DE19681033D2 (de) 1995-11-16 1996-11-14 Verfahren zur Quantifizierung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE59609347T Expired - Lifetime DE59609347D1 (de) 1995-11-16 1996-11-14 Verfahren zur quantifizierung von tumorzellen in einer körperflüssigkeit und dazu geeignete testkits

Country Status (9)

Country Link
US (1) US6582904B2 (de)
EP (1) EP0861334B2 (de)
JP (1) JP2000512126A (de)
CN (1) CN1202206A (de)
AT (1) ATE219151T1 (de)
AU (1) AU1867397A (de)
CA (1) CA2237589A1 (de)
DE (2) DE59609347D1 (de)
WO (1) WO1997018322A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582904B2 (en) 1995-11-16 2003-06-24 Michael W. Dahm Method of quantifying tumour cells in a body fluid and a suitable test kit
US6607898B1 (en) 1996-03-26 2003-08-19 Oncomedx, Inc. Method for detection of hTR and hTERT telomerase-associated RNA in plasma or serum
DE19757300A1 (de) * 1997-12-22 1999-06-24 Roche Diagnostics Gmbh Nachweis von Harnblasenkarzinom in einer Urinprobe
DE19804372A1 (de) * 1998-02-04 1999-08-05 Michael W Dr Dr Dahm Verfahren zur quantitativen Bestimmung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits
DE19836559A1 (de) * 1998-08-12 2000-03-23 Antigen Gmbh Gefäß zur Entnahme von Blut
US7947236B2 (en) 1999-12-03 2011-05-24 Becton, Dickinson And Company Device for separating components of a fluid sample
EP1158055A1 (de) * 2000-05-26 2001-11-28 Xu Qi University of Teaxs Laboratoire de Leucémie Chen Verfahren zur Diagnose von Krebs
US8044259B2 (en) 2000-08-03 2011-10-25 The Regents Of The University Of Michigan Determining the capability of a test compound to affect solid tumor stem cells
US6984522B2 (en) * 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
EP2359689B1 (de) 2002-09-27 2015-08-26 The General Hospital Corporation Mikrofluid-Vorrichtung zur Zelltrennung, sowie Verwendung derselben
JP2004350685A (ja) * 2003-05-07 2004-12-16 Tosoh Corp 微小転移の検出法
TWI340168B (en) * 2003-05-07 2011-04-11 Tosoh Corp Method of detecting micrometastasis
WO2005084374A2 (en) * 2004-03-03 2005-09-15 The General Hospital Corporation Magnetic device for isolation of cells and biomolecules in a microfluidic environment
CN1673387B (zh) * 2004-03-24 2010-12-01 董强刚 实时定量pcr检测血液样品中癌细胞的方法
US7939251B2 (en) 2004-05-06 2011-05-10 Roche Molecular Systems, Inc. SENP1 as a marker for cancer
JP2006014723A (ja) * 2004-06-01 2006-01-19 Sumitomo Chemical Co Ltd コモンマーモセット由来のグリセルアルデヒド３リン酸デヒドロゲナーゼ遺伝子及びその利用
US20060071519A1 (en) * 2004-07-26 2006-04-06 Heide Diana D Furniture combination useful for hiding pet products
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
EP2594631A1 (de) * 2005-04-05 2013-05-22 Cellpoint Diagnostics Vorrichtungen und Verfahren zur Nachweisen von zirkulierenden Tumorzellen und anderen Partikeln
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
AU2006308847C1 (en) * 2005-10-31 2012-05-10 Oncomed Pharmaceuticals, Inc. Compositions and methods for treating and diagnosing cancer
US20080019961A1 (en) * 2006-02-21 2008-01-24 Regents Of The University Of Michigan Hedgehog signaling pathway antagonist cancer treatment
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US20080070792A1 (en) 2006-06-14 2008-03-20 Roland Stoughton Use of highly parallel snp genotyping for fetal diagnosis
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
WO2008092002A2 (en) 2007-01-24 2008-07-31 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing pancreatic cancer
JP5385383B2 (ja) 2008-07-21 2014-01-08 ベクトン・ディキンソン・アンド・カンパニー 密度相分離装置
EP2517793B1 (de) 2008-07-21 2013-09-11 Becton, Dickinson and Company Dichtephasentrennvorrichtung
CA2819470C (en) 2008-07-21 2016-05-10 Becton, Dickinson And Company Density phase separation device
EP2334812B1 (de) 2008-09-20 2016-12-21 The Board of Trustees of The Leland Stanford Junior University Nichtinvasive diagnose von fötaler aneuploidie mittels sequenzieren
RS55784B1 (sr) * 2008-11-11 2017-07-31 Univ Michigan Regents Anti-cxcr1 kompozicije i postupci
BR122021008538B1 (pt) 2009-05-15 2022-05-24 Becton, Dickinson And Company Conjunto de separação para separar uma amostra de fluido em primeira e segunda fases
EP2453243A1 (de) * 2010-11-11 2012-05-16 Cosmo S.p.A. Verfahren zur Diagnose und/oder Überwachung der Entwicklung eines Tumors
US9694359B2 (en) 2014-11-13 2017-07-04 Becton, Dickinson And Company Mechanical separator for a biological fluid

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3741400A (en) 1970-06-15 1973-06-26 J Dick Blood sample container
US3945928A (en) 1974-02-27 1976-03-23 Becton, Dickinson And Company Serum/plasma separators with centrifugal valves
US3887464A (en) 1974-02-27 1975-06-03 Becton Dickinson Co Serum/plasma separator with centrifugal valve seal
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US5175270A (en) 1986-09-10 1992-12-29 Polyprobe, Inc. Reagents for detecting and assaying nucleic acid sequences
US5270171A (en) 1987-03-06 1993-12-14 Boris Cercek Cancer-associated SCM-recognition factor, preparation and method of use
US4932207A (en) 1988-12-28 1990-06-12 Sundstrand Corporation Segmented seal plate for a turbine engine
GB2260811B (en) 1991-10-23 1995-07-05 Yorkshire Cancer Research Camp Detection of malignant tumours
DE69323230D1 (de) 1992-04-15 1999-03-11 Cobe Lab Temperaturkontrollierte Zentrifuge
US5561041A (en) 1993-11-12 1996-10-01 The Johns Hopkins University School Of Medicine Nucleic acid mutation detection by analysis of sputum
US5776679A (en) 1994-07-07 1998-07-07 Geron Corporation Assays for the DNA component of human telomerase
CZ3497A3 (en) * 1994-07-07 1997-10-15 Geron Corp Rna component of mammal telomerase, oligonucleotide, recombinant expression plasmid containing the oligonucleotide, process for preparing eukaryotic host cell, process for preparing a recombinant telomerase enzyme
US5583016A (en) 1994-07-07 1996-12-10 Geron Corporation Mammalian telomerase
ATE216425T1 (de) 1994-08-13 2002-05-15 Roche Diagnostics Gmbh Verwendung von interferon-gamma zur vermeidung der proliferation und differenzierung der primitiven hämapoietischen vorläuferzellen
JP3397795B2 (ja) 1994-08-31 2003-04-21 デンドレオン コーポレイション 細胞分離装置および方法
US5663051A (en) 1994-08-31 1997-09-02 Activated Cell Therapy, Inc. Separation apparatus and method
US5840502A (en) 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US5648223A (en) 1994-08-31 1997-07-15 Activated Cell Therapy, Inc. Methods for enriching breast tumor cells
US5577513A (en) 1994-08-31 1996-11-26 Activated Cell Therapy, Inc. Centrifugation syringe, system and method
US5856096A (en) * 1995-09-20 1999-01-05 Ctrc Research Foundation Rapid and sensitive assays for detecting and distinguishing between processive and non-processive telomerase activities
US6582904B2 (en) 1995-11-16 2003-06-24 Michael W. Dahm Method of quantifying tumour cells in a body fluid and a suitable test kit
EP0958046B8 (de) 1995-12-11 2012-04-25 Dendreon Corporation Zusammensetzung, kit und verfahren zur trennung von zellen
US5770422A (en) 1996-07-08 1998-06-23 The Regents Of The University Of California Human telomerase
WO1998002581A1 (en) 1996-07-17 1998-01-22 Brian Liu Telomerase assay for precancerous lesions of the uterine cervix
AU734089B2 (en) 1996-10-01 2001-06-07 Geron Corporation Human telomerase catalytic subunit
CA2272924A1 (en) 1996-11-22 1998-05-28 Shiloov Medical Technologies Ltd. A whole blood/mitogen assay for the early detection of a subject with cancer and kit
WO1998037181A2 (en) 1997-02-20 1998-08-27 Whitehead Institute For Biomedical Research Telomerase catalytic subunit gene and encoded protein
US5860937A (en) 1997-04-30 1999-01-19 Becton, Dickinson & Company Evacuated sample collection tube with aqueous additive
CA2294646A1 (en) 1997-06-20 1998-12-30 Bayer Aktiengesellschaft Human catalytic telomerase sub-unit and its diagnostic and therapeutic use
ATE240398T1 (de) 1997-07-11 2003-05-15 Fleckenstein Bernard Prof Dr Von kaposi-sarkom assoziiertem herpes-virus (kshv,hhv-8) kodiertes polypeptid und dessen verwendung in diagnostik und therapie
DE19804372A1 (de) 1998-02-04 1999-08-05 Michael W Dr Dr Dahm Verfahren zur quantitativen Bestimmung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits
DE19904267A1 (de) 1999-02-03 2000-08-10 Michael W Dahm Verfahren zur Anreicherung von Tumorzellen aus einer Körperflüssigkeit und dazu geeigneter Kit

Also Published As

Publication number Publication date
EP0861334B1 (de) 2002-06-12
DE59609347D1 (de) 2002-07-18
ATE219151T1 (de) 2002-06-15
WO1997018322A2 (de) 1997-05-22
CA2237589A1 (en) 1997-05-22
WO1997018322A3 (de) 1997-07-31
AU1867397A (en) 1997-06-05
EP0861334A2 (de) 1998-09-02
EP0861334B2 (de) 2008-04-09
CN1202206A (zh) 1998-12-16
US20020012969A1 (en) 2002-01-31
US6582904B2 (en) 2003-06-24
JP2000512126A (ja) 2000-09-19

Similar Documents

Publication Publication Date Title
DE19681033D2 (de) Verfahren zur Quantifizierung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits
DE69607830T2 (de) Verfahren zur isothermer amplifikation von nukleinsäure molekülen
ES8507181A1 (es) Un metodo para la determinacion de un polinucleotido
ATA183094A (de) Verfahren zur quantifizierung von genomischer dna
ATE255168T1 (de) Massenspektroskopische verfahren zur sequenzierung von nukleinsäuren
ATE206465T1 (de) Verfahren zur unterdrückung der hemmung von enzym-vermittelten reaktionen durch ionische detergentien
ATE398187T1 (de) Verfahren zum nachweis von ziel-nukleinsäuren mittels pcr
ATE54028T1 (de) Hybridisierungstest fuer nukleinsaeure mittels anwendung von nachweisbaren antihybridantik¯rpern.
ATE510927T1 (de) Verfahren zur quantitativen bestimmung von tumorzellen in einer körperflüssigkeit und dazu geeignete testkits
ATE188292T1 (de) Verfahren zur nachweis von marijuana in einer haar probe
DE60014399D1 (de) Schnelle und wirksame dns-immobilisierung aus einer probe ohne die verwendung von zelllysereagenzien
NO175380C (no) Fremgangsmåte til kvantitativ bestemmelse av nukleinsyremolekyler og reagenspakke til bruk ved utförelse av fremgangsmåten
EP0128018A3 (en) Molecular genetic probe, and method of forming same, assay technique and kit using said molecular genetic probe
DE69012440T2 (de) Verfahren zur Bestimmung von Nukleinsäuren.
ATE142020T1 (de) Verfahren zur haaranalyse
WO2002052038A3 (en) Method for normalizing the relative intensities of detection signals in hybridization arrays
ATE470148T1 (de) Verfahren zum vorbehandeln einer probe
WO2002090586A3 (en) Analytical method and kit
ATE333519T1 (de) Electrochemisches verfahren zum nachweis von nukleinsäuren
WO1996019587A3 (en) Methods of immobilizing oligonucleotides to solid support materials and methods of using support bound oligonucleotides
DE59915095D1 (de) Mit nukleinsäuren beschichtete reaktionsräume, verfahren zu ihrer herstellung und ihre verwendung
ATA144399A (de) Verfahren zur herstellung eines qualitätsgesicherten pools biologischer proben
ATE269417T1 (de) Verfahren zur erkennung und messung von gespleisten nukleinsäuren
ATE305980T1 (de) Verwendung von abfangsonden beim nachweis von nukleinsäuren

Legal Events

Date Code Title Description
8131 Rejection